FILED - 11 January 2016, Thuringia, Rudolstadt: A view of the company grounds of the pharmaceutical company Sandoz Aeropharm in Rudolstadt. Sandoz, a unit of Swiss biopharmaceutical major Novartis, said on Monday that it has completed acquiring the worldwide brand rights of the antifungal agent Mycamine from Astellas Pharma, a Japanese pharmaceutical company. Photo: Sebastian Kahnert/dpa-Zentralbild/dpa
Fecha:
leer más
11/01/2016.
leer menos
Foto de archivo